Filing Details
- Accession Number:
- 0001209191-16-141609
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-09-15 16:32:25
- Reporting Period:
- 2016-09-14
- Filing Date:
- 2016-09-15
- Accepted Time:
- 2016-09-15 16:32:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1445283 | Proteostasis Therapeutics Inc. | PTI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1219855 | James M Barrett | 1954 Greenspring Drive Suite 600 Timonium MD 21093 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-09-14 | 461,538 | $13.00 | 3,554,610 | No | 4 | P | Indirect | See Note 1 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See Note 1 |
Footnotes
- The Reporting Person is a manager of NEA 12 GP, LLC, ("NEA 12 GP") which is the sole general partner of NEA Partners 12, Limited Partnership ("NEA Partners 12"). NEA Partners 12 is the sole general partner of New Enterprise Associates 12, Limited Partnership ("NEA 12"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 12 in which the Reporting Person has no pecuniary interest.
Billionaire Hedge Funds
